1 – 10 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers
(
- Contribution to journal › Article
-
Mark
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism
(
- Contribution to journal › Article
-
Mark
Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations
(
- Contribution to journal › Article
-
Mark
REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways
(
- Contribution to journal › Article
- 2016
-
Mark
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios : better diagnostic markers of Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.
(
- Contribution to journal › Article
- 2015
-
Mark
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
(
- Contribution to journal › Article
- 2014
-
Mark
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls
(
- Contribution to journal › Article